or Try an Advanced Search...

    Protein Kinase Inhibitor Stocks List

    Symbol Grade Name % Change
    ALLR F Allarity Therapeutics, Inc. -9.90
    NTBL F Notable Labs, Ltd. -1.05
    EXEL F Exelixis, Inc. 0.00
    BBIO F BridgeBio Pharma, Inc. 0.93
    AVBP F ArriVent BioPharma, Inc. 0.06
    PRLD D Prelude Therapeutics Incorporated -0.78
    PBYI D Puma Biotechnology Inc -4.94
    ACLX D Arcellx, Inc. -0.04
    COGT C Cogent Biosciences, Inc. 0.53
    CRIS B Curis, Inc. -1.16
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Tyrosine Kinase Biotechnology Solid Tumors Non Small Cell Lung Cancer Tyrosine Kinase Receptors Acute Myeloid Leukemia Biopharmaceutical Breast Cancer Cancer Treatment Clinical Medicine Drugs Enzymes Lung Cancer Lymphoma Multiple Myeloma Myelodysplastic Syndrome Organ Systems Orphan Drug Phosphoinositide 3 Kinase Inhibitor

    Related ETFs - A few ETFs which own one or more of the above listed Protein Kinase Inhibitor stocks.

    Symbol Grade Name Weight
    IDNA C iShares Genomics Immunology and Healthcare ETF 6.56
    XBI D SPDR S&P Biotech ETF 3.48
    BBP C BioShares Biotechnology Products Fund 3.41
    CNCR D Loncar Cancer Immunotherapy ETF 3.34
    FBT D First Trust Amex Biotech Index Fund 3.21
    View all Protein Kinase Inhibitor ETFs...
    Compare ETFs
    Compare CNCR to FBT Compare IDNA to CNCR Compare IDNA to FBT

        Protein Kinase Inhibitor Stocks Recent News

        Date Stock Title
        May 6 EXEL Exelixis (EXEL) International Revenue Performance Explored
        May 6 CRIS Curis Q1 2024 Earnings Preview
        May 6 ALLR Allarity exceeds Nasdaq's minimum equity requirement
        May 6 ALLR Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
        May 5 PBYI Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
        May 5 PBYI Puma Biotechnology: A Story In Flux Heading Into Mid-2024
        May 4 PBYI Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 4 BBIO What You Need To Know About The BridgeBio Pharma, Inc. (NASDAQ:BBIO) Analyst Downgrade Today
        May 3 PBYI Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
        May 3 BBIO BridgeBio Pharma First Quarter 2024 Earnings: Beats Expectations
        May 3 BBIO BridgeBio Oncology Therapeutics launches with $200m funding
        May 3 PBYI Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
        May 3 PBYI Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript
        May 2 PBYI Puma Biotechnology, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 PBYI Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
        May 2 PBYI Puma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25M
        May 2 PBYI Puma Biotechnology Reports First Quarter Financial Results
        May 2 EXEL Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
        May 2 EXEL Exelixis: With Patent Litigation Decision Due Soon, There Are Options
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Tyrosine Kinase Biotechnology Solid Tumors Non Small Cell Lung Cancer Tyrosine Kinase Receptors Acute Myeloid Leukemia Biopharmaceutical Breast Cancer Cancer Treatment Clinical Medicine Drugs Enzymes Lung Cancer Lymphoma Multiple Myeloma Myelodysplastic Syndrome Organ Systems Orphan Drug Phosphoinositide 3 Kinase Inhibitor
        Protein Kinase Inhibitor

        Protein kinase inhibitors are drugs that block the activity of one or more protein kinases. Protein kinases are enzymes that add phosphate groups to proteins, which can alter their activity and function. Protein kinase inhibitors are used to treat a variety of diseases, including cancer, inflammation, and autoimmune disorders.

        Browse All Tags